Anger, Mood and Quality of Life in Patients with Epilepsy Treated with Eslicarbazepine Acetate

被引：0

作者：

Toledo, M. ^{[1
]}

Mazuela, G. ^{[1
]}

Quintana, M. ^{[1
]}

Cazorla, S. ^{[1
]}

Mauri, J. A. ^{[2
]}

Rodriguez-Osorio, X. ^{[3
]}

Lopez-Gonzalez, F. J. ^{[3
]}

Gomez-Eguilaz, M. ^{[4
]}

Barcala, M. ^{[5
]}

Esteve, P. ^{[6
]}

Baiges, J. J. ^{[6
]}

Abril-Jaramillo, J. ^{[7
]}

Rodriguez-Uranga, J. ^{[7
]}

Castro-Vilanova, M. D. ^{[8
]}

Abraira del Fresno, L. ^{[1
]}

Salas-Puig, J. ^{[1
]}

Santamarina, E. ^{[1
]}

机构：

[1] Vall dHebron Hosp, Dept Neurol, Epilepsy Unit, Barcelona, Spain

[2] Hosp Clin Univ Lozano Blesa, Dept Neurol, Epilepsy Unit, Zaragoza, Spain

[3] Hosp Clin Univ Santiago, Dept Neurol, Epilepsy Unit, Santiago De Compostela, Spain

[4] Hosp San Pedro, Dept Neurol, Epilepsy Unit, Logrono, Spain

[5] Hosp Univ Tarragona Joan XXIII, Dept Neurol, Epilepsy Unit, Tarragona, Spain

[6] Hosp Verge de la Cinta, Dept Neurol, Epilepsy Unit, Tortosa, Spain

[7] Ctr Neurol Avanzada, Epilepsy Unit, Seville, Spain

[8] Hosp Alvaro Cunqueiro, Dept Neurol, Epilepsy Unit, Vigo, Spain

来源：

EPILEPSIA | 2018年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

p595

引用

页码：S271 / S271

页数：1

共 50 条

[21] Effects of eslicarbazepine acetate on lipid profile and sodium levels in patients with epilepsy
Pulitano, Patrizia
Franco, Valentina
Mecarelli, Oriano
Brienza, Marianna
Davassi, Chiara
Russo, Emilio
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 53 : 1 - 3
[22] Eslicarbazepine acetate: An update on efficacy and safety in epilepsy
Verrotti, Alberto
Loiacono, Giulia
Rossi, Alessandra
Zaccara, Gaetano
EPILEPSY RESEARCH, 2014, 108 (01) : 1 - 10
[23] QUALITY OF LIFE IN PATIENTS WITH REFRACTORY EPILEPSY TREATED WITH LAMOTRIGINE
Nikodijevic, D.
Petrovska-Cvetkovska, D.
Dzonov, I.
Cvetkovska, E.
Kuzmanovski, I.
Maksimovska, B.
EPILEPSIA, 2009, 50 : 166 - 167
[24] Health-related quality of life in patients treated with eslicarbazepine acetate monotherapy: Pooled analysis from two registered clinical trials
Cramer, Joyce A.
Rajagopalan, Krithika
Anastassopoulos, Kathryn Plante
Blum, David
EPILEPSY & BEHAVIOR, 2019, 92 : 31 - 35
[25] Quality of life and mood assessment in conservatively treated cavernous malformation-related epilepsy
Rauschenbach, Laurel
Bartsch, Pauline
Santos, Alejandro N.
Lenkeit, Annika
Oppong, Marvin Darkwah
Wrede, Karsten H.
Jabbarli, Ramazan
Chmielewski, Witold X.
Schmidt, Boerge
Quesada, Carlos M.
Forsting, Michael
Sure, Ulrich
Dammann, Philipp
BRAIN AND BEHAVIOR, 2022, 12 (06):
[26] Efficacy and tolerability of eslicarbazepine acetate as monotherapy in patients of newly diagnosed focal epilepsy
Saxena, S.
Singh, S.
EUROPEAN PSYCHIATRY, 2021, 64 : S774 - S775
[27] The association of mood with quality of life ratings in epilepsy
Tracy, J. I.
Dechant, V.
Sperling, M. R.
Cho, R.
Glosser, D.
NEUROLOGY, 2007, 68 (14) : 1101 - 1107
[28] ESLICARBAZEPINE ACETATE (ESL) IN TREATMENT OF CHILDHOOD FOCAL EPILEPSY
Larsen, M.
Olofsson, K.
Jepsen, B.
Gellert, P.
McMurray, R.
Nikanorova, M.
EPILEPSIA, 2017, 58 : S105 - S105
[29] Efficacy and Safety of Adjunctive Eslicarbazepine Acetate in Patients Of Pediatric Age With Focal Epilepsy
Lattanzi, S.
Brigo, F.
Grillo, E.
Cagnetti, C.
Verrotti, A.
Zaccara, G.
Silvestrini, M.
EPILEPSIA, 2018, 59 : S171 - S172
[30] Eslicarbazepine acetate: a new option for the treatment of focal epilepsy
Mestre, Tiago
Ferreira, Joaquim J.
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (02) : 221 - 229

← 1 2 3 4 5 →